Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group (Q33496743)
scientific article
Language:
(P31) (Q13442814)
(P304) 205-207
(P433) 2
(P478) 7
(P577) Thursday, February 1, 1996
(P921) (Q42824440)
(Q16)
(P1433) (Q326122)
(P1476) "Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group" (language: en)
(P2093) D Macdonald
G Cairncross
D Stewart
P Forsyth
C Sawka
N Wainman
E Eisenhauer
other details
description scientific article

External Links